1h Free Analyst Time
The induced pluripotent stem cells production market is forecasted to grow by USD 1841.79 million during 2023-2028, accelerating at a CAGR of 11.66% during the forecast period. The report on the induced pluripotent stem cells production market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of several chronic disorders, increasing adoption of ipscs in drug discovery and toxicity screening applications, and growing demand for ipscs for personalized medicines.
The induced pluripotent stem cells production market is segmented as below:
By End-user
- Hospitals
- Research institutes
- Biotechnology companies
- Others
By Product
- Consumable and kits
- Instrument
- Services and others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the induced pluripotent stem cells production market covers the following areas:
- Induced pluripotent stem cells production market sizing
- Induced pluripotent stem cells production market forecast
- Induced pluripotent stem cells production market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global induced pluripotent stem cells production market: Allele Biotechnology and Pharmaceuticals Inc., ALSTEM, Applied Biological Materials Inc., Applied StemCell, ATCC, Axol Biosciences Ltd., Becton Dickinson and Co., Bio Techne Corp., Board of Regents of the University of Wisconsin System, Creative Biolabs, Cyagen Biosciences, Cynata Therapeutics Ltd., Evotec SE, Fate Therapeutics Inc., FUJIFILM Corp., Hitachi Ltd., LIFE and BRAIN GmbH, Lonza Group Ltd., Ncardia Services B.V., REPROCELL Inc., Sartorius AG, STEMCELL Technologies Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advancements in cell reprogramming techniques."
According to the report, one of the major drivers for this market is the rising prevalence of several chronic disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Allele Biotechnology and Pharmaceuticals Inc.
- ALSTEM
- Applied Biological Materials Inc.
- Applied StemCell
- ATCC
- Axol Biosciences Ltd.
- Becton Dickinson and Co.
- Bio Techne Corp.
- Board of Regents of the University of Wisconsin System
- Creative Biolabs
- Cyagen Biosciences
- Cynata Therapeutics Ltd.
- Evotec SE
- Fate Therapeutics Inc.
- FUJIFILM Corp.
- Hitachi Ltd.
- LIFE and BRAIN GmbH
- Lonza Group Ltd.
- Ncardia Services B.V.
- REPROCELL Inc.
- Sartorius AG
- STEMCELL Technologies Inc.
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
